MALDI-TOF mass spectrometry proteomic profiling to discriminate response to the combination of bevacizumab and erlotinib in non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Salmon, JS
Sandler, A
Billheimer, D
Herbst, RS
Tran, HT
Tsao, A
Dang, TP
机构：
[1] Vanderbilt Univ Sch Med, Nashville, TN USA
[2] MD Anderson Canc Ctr, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：626S / 626S
页数：1
相关论文
共 50 条
  • [1] Predictive value of serum MALDI-TOF proteomic profiling from patients treated with erlotinib and bevacizumab for survival in patients with non-small cell lung cancer (NSCLC) treated with erlotinib alone
    Dang, T. P.
    Salmon, J. S.
    Chen, H.
    Chen, S.
    Lee, J. W.
    Sandler, A. B.
    Herbst, R. S.
    Brahmer, J.
    Carbone, D. P.
    Shyr, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Diagnostic accuracy of MALDI-TOF mass spectrometry for non-small cell lung cancer: a meta-analysis
    Lu, Zhaolian
    Chen, Yingjian
    Jing, Xinyan
    Hu, Chengjin
    BIOMARKERS, 2018, 23 (03) : 245 - 252
  • [3] Response prediction by MALDI-TOF-MS serum peptide profiling of combination treatment with sorafenib and erlotinib in patients with non-small cell lung cancer
    Rovithi, Maria
    Lind, Joline S.
    Pham, Thang V.
    Knol, Jaco C.
    Verheul, Henk M. W.
    Smit, Egbert F.
    Jimenez, Connie R.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] MALDI-TOF mass spectrometric immunoassay of multiple tumor biomarkers for non-small cell lung cancer screening
    Wang, Mengchen
    Zhu, Chengxiang
    Feng, Nan
    Li, Yiran
    Sun, Jiahui
    Ju, Huangxian
    TALANTA, 2025, 286
  • [5] Proteomic profiling of a snake venom using high mass detection MALDI-TOF mass spectrometry
    Yanes, Oscar
    Aviles, Francesc X.
    Wenzel, Ryan
    Nazabal, Alexis
    Zenobi, Renato
    Calvete, Juan J.
    JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 2007, 18 (04) : 600 - 606
  • [6] Rapid Proteomic Profiling by MALDI-TOF Mass Spectrometry for Better Brain Tumor Classification
    Petre, Graciane
    Durand, Harmonie
    Pelletier, Laurent
    Poulenard, Margot
    Nugue, Guillaume
    Ray, Pierre F.
    Rendu, John
    Coutton, Charles
    Berger, Francois
    Bidart, Marie
    PROTEOMICS CLINICAL APPLICATIONS, 2020, 14 (05)
  • [7] Proteomic Profiling and Protein Identification by MALDI-TOF Mass Spectrometry in Unsequenced Parasitic Nematodes
    Millares, Paul
    LaCourse, E. James
    Perally, Samirah
    Ward, Deborah A.
    Prescott, Mark C.
    Hodgkinson, Jane E.
    Brophy, Peter M.
    Rees, Huw H.
    PLOS ONE, 2012, 7 (03):
  • [8] Combination of erlotinib and bevacizumab in non small cell lung cancer patients
    Boutsikou, Efimia
    Kontakiotis, Theodoros
    Zarogoulidis, Pavlos
    Pataka, Paraskevi
    Zarogoulidis, Kostas
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [9] Molecular profiling of lung cancer specimens and liquid biopsies using MALDI-TOF mass spectrometry
    Eleonora Bonaparte
    Chiara Pesenti
    Laura Fontana
    Rossella Falcone
    Leda Paganini
    Anna Marzorati
    Stefano Ferrero
    Mario Nosotti
    Paolo Mendogni
    Claudia Bareggi
    Silvia Maria Sirchia
    Silvia Tabano
    Silvano Bosari
    Monica Miozzo
    Diagnostic Pathology, 13
  • [10] Molecular profiling of lung cancer specimens and liquid biopsies using MALDI-TOF mass spectrometry
    Bonaparte, Eleonora
    Pesenti, Chiara
    Fontana, Laura
    Falcone, Rossella
    Paganini, Leda
    Marzorati, Anna
    Ferrero, Stefano
    Nosotti, Mario
    Mendogni, Paolo
    Bareggi, Claudia
    Sirchia, Silvia Maria
    Tabano, Silvia
    Bosari, Silvano
    Miozzo, Monica
    DIAGNOSTIC PATHOLOGY, 2018, 13
12345